Overexpression of CST4 promotes gastric cancer aggressiveness by activating the ELFN2 signaling pathway.

about

Overexpression of CST4 promotes gastric cancer aggressiveness by activating the ELFN2 signaling pathway.

Item

http://www.wikidata.org/entity/Q47160638

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Overexpression of CST4 promote ...... g the ELFN2 signaling pathway.

@en

Overexpression of CST4 promote ...... g the ELFN2 signaling pathway.

@nl

type

Item

label

Overexpression of CST4 promote ...... g the ELFN2 signaling pathway.

@en

Overexpression of CST4 promote ...... g the ELFN2 signaling pathway.

@nl

prefLabel

Overexpression of CST4 promote ...... g the ELFN2 signaling pathway.

@en

Overexpression of CST4 promote ...... g the ELFN2 signaling pathway.

@nl

P1476

Overexpression of CST4 promote ...... g the ELFN2 signaling pathway.

@en

P2093

Da Wei Li

http://www.w3.org/2001/XMLSchema#string

Hong Jie Song

http://www.w3.org/2001/XMLSchema#string

Jing Jing Zhang

http://www.w3.org/2001/XMLSchema#string

Yi Qiang Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

Characterization of two members (CST4 and CST5) of the cystatin gene family and molecular evolution of cystatin genes

An integrated transcriptomic and computational analysis for biomarker identification in gastric cancer

FOXM1 promotes lung adenocarcinoma invasion and metastasis by upregulating SNAIL.

A comprehensive survey of genomic alterations in gastric cancer reveals systematic patterns of molecular exclusivity and co-occurrence among distinct therapeutic targets.

Differential secretome analysis reveals CST6 as a suppressor of breast cancer bone metastasis

Overexpression of TRIM14 promotes tongue squamous cell carcinoma aggressiveness by activating the NF-κB signaling pathway

Dual contrasting roles of cysteine cathepsins in cancer progression: apoptosis versus tumour invasion.

MFN2 suppresses cancer progression through inhibition of mTORC2/Akt signaling.

DDX5 promotes gastric cancer cell proliferation in vitro and in vivo through mTOR signaling pathway

Clinical significance of lymph node metastasis in gastric cancer.

P304

2290-2304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29218251

http://www.w3.org/2001/XMLSchema#string

P921

overexpression

P932

5714756

http://www.w3.org/2001/XMLSchema#string